Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The new immunosuppressive era.

A I Lo Monte1, G Ciancio, G Burke

  • 1Jackson Memorial Hospital Department of Surgery, University of Miami School of Medicine, Florida, USA.

Annali Italiani Di Chirurgia
|June 15, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Requirement analysis for an AI-based AR assistance system for surgical tools in the operating room: stakeholder requirements and technical perspectives.

International journal of computer assisted radiology and surgery·2024
Same author

Pre-operative interventional radiology: could it have a role before complex laparoscopic surgery?

La Clinica terapeutica·2021
Same author

Colour Doppler-guided Haemorrhoidal Artery Ligation: a possible evolution of Transanal Haemorrhoidal Dearterialisation.

La Clinica terapeutica·2021
Same author

Tertiary hyperparathyroidism: a review.

La Clinica terapeutica·2021
Same author

Scar endometriosis: not a rare cause for a painful scar.

La Clinica terapeutica·2021
Same author

Lumevis ™: a new medical device to prepare patients for esophagogastroduodenoscopy. Experimental clinical study.

La Clinica terapeutica·2020
Same journal

Comparison of Small-Incision Tension-Free Mesh Repair With Scrotal Drainage and Laparoscopic Transabdominal Preperitoneal Repair for Inguinal Hernia: A Retrospective Cohort Study.

Annali italiani di chirurgia·2026
Same journal

Phyllodes Tumors: From National Guidelines to European Evidence and Collaboration.

Annali italiani di chirurgia·2026
Same journal

Anorectal Melanoma Management Evolution: A Narrative Review.

Annali italiani di chirurgia·2026
Same journal

Correlation and Responsiveness of Objective and Subjective Measures in Evaluating Periorbital Swelling After Upper Blepharoplasty: A Retrospective Study Using 3D Stereophotography and Visual Analogue Scale.

Annali italiani di chirurgia·2026
Same journal

Colonic Continuity After Splenic Flexure Resection: Does the Orientation of the Anastomosis Matter? A Retrospective Cohort Study.

Annali italiani di chirurgia·2026
Same journal

Aortic Repair in Landing Zone 2: From Chimney Technique to Branched Graft.

Annali italiani di chirurgia·2026
See all related articles

New immunosuppressive drugs and strategies aim to prevent organ transplant rejection and reduce risks like infections and toxicity. These agents target T lymphocytes to improve allograft survival in transplantation.

Area of Science:

  • Immunology and Transplantation Medicine

Background:

  • Immunosuppression is vital for preventing organ transplant rejection but carries risks such as increased neoplasm, opportunistic infections, and end-organ toxicity.
  • Graft rejection (acute and chronic) remains a significant challenge, leading to reduced or lost allograft function despite patient compliance.

Purpose of the Study:

  • To provide an update on novel immunosuppressive agents and emerging strategies for solid organ transplantation.
  • To discuss advancements in managing transplant recipients and overcoming limitations of current immunosuppressive therapies.

Main Methods:

  • Review of current and emerging immunosuppressive drugs.
  • Analysis of new therapeutic strategies in solid organ transplantation.
  • Focus on agents targeting T lymphocyte activation and proliferation.

Related Experiment Videos

Main Results:

  • Introduction of new immunosuppressive agents to combat allograft rejection.
  • Development of strategies to manage cyclosporine-resistant rejection.
  • Continued focus on non-specific T-cell inhibition as a primary mechanism.

Conclusions:

  • Advancements in immunosuppression offer improved options for preventing organ transplant rejection.
  • New agents and strategies aim to mitigate the risks associated with immunosuppression.
  • Ongoing research focuses on enhancing allograft survival and patient outcomes in transplantation.